Very high HDI countries | High HDI countries | Medium HDI countries | HDI not specified | |
Total number of papers | All=11 Brunei: 0 Hong Kong: 2 Japan: 3 Singapore: 2 South Korea: 4 | All=12 China: 11 Malaysia: 1 Mongolia: 0 | All=4 Cambodia: 2 Laos: 0 Philippines: 2 Vietnam: 0 | All=3 Taiwan: 3 Macao: 0 |
Coverage* | ||||
National | 6 | 0 | 1 | 2 |
Subnational | 3 | 5 | 2 | 2 |
Facility/facilities | 5 | 7 | 1 | 1 |
Study period† | ||||
Prior to 2000 | 6 | 3 | 2 | 3 |
2000 onwards | 2 | 6 | 2 | 0 |
Study period spans pre-2000 and post-2000 | 3 | 2 | 0 | 0 |
Metric‡ | ||||
Prevalence: general population or population subgroup | 4 | 4 | 2 | 2 |
RHD frequency among hospital/medical/cardiovascular/surgical/obstetric admissions | 4 | 5 | 1 | 1 |
RHD as a proportion of echos performed | 0 | 2 | 0 | 0 |
RHD mortality rates or proportions** | 5 | 1 | 1 | 2 |
Data source | ||||
Screening/clinical exam in other context | 2 | 4 | 2 | 2 |
Hospital admissions data or surgical database | 4 | 4 | 1 | 1 |
Health insurance data | 2 | 0 | 0 | 0 |
Echocardiography database (including echo database for inpatients) | 0 | 3 | 0 | 0 |
Mortality data | 5 | 1 | 1 | 2 |
Numbers do not add to total number of papers as some reported multiple measures.
*Any study reporting on health facility populations denoted here as ‘facility’, regardless of whether the facility catchment area is national or subnational.
†For one paper, study period not explicitly stated.
Note several papers, particularly among those published pre-1990, have inconsistent results reported throughout the text.
‡Some studies reported ARF and RHD in the same point estimate. ** does not include absolute counts only
ARF, acute rheumatic fever; HDI, Human Development Index; RHD, rheumatic heart disease.